Role of TRP channels in carcinogenesis and metastasis: Pathophysiology and regulation by non-coding RNAs

Assiya Turgambayeva1, Samal Duisekova1, Gulnara Tashenova2

  • 1Department Public Health and Management, NJSC, Astana Medical University, Astana, Kazakhstan.

PubMed

Insights

Transient receptor potential (TRP) channels, Nobel Prize-winning discoveries, are key players in cancer. This review highlights TRP channel roles in cancer onset and progression, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Physiology

Background:

  • Nobel Prize-winning research identified Transient Receptor Potential (TRP) channels for temperature and touch sensation.
  • TRP channels are increasingly recognized for their significant roles in various cancer types.
  • Decades of research illuminate the involvement of TRP channels in cancer development and progression.

Purpose of the Study:

  • To summarize recent advancements in understanding TRP channel biology in the context of cancer.
  • To review the distinct roles of specific TRP channel families (TRPV, TRPM, TRPC) in cancer.
  • To explore the regulatory role of non-coding RNAs in TRP channel function concerning cancer.

Main Methods:

  • Literature review synthesizing current research on TRP channels and cancer.
  • Categorization of TRP channel functions based on emerging evidence in specific cancer types.
  • Analysis of studies investigating non-coding RNA regulation of TRP channels in cancer.

Main Results:

  • TRP channels, including TRPV, TRPM, and TRPC families, exhibit distinct roles in cancer onset and progression.
  • Specific TRP channels like TRPV1, TRPV5, TRPM3, and TRPM7 are implicated in various cancers.
  • Non-coding RNAs emerge as critical regulators influencing TRP channel activity in cancer.

Conclusions:

  • TRP channels represent promising therapeutic targets for cancer treatment.
  • Further research into TRP channel mechanisms, particularly non-coding RNA regulation, is crucial for a comprehensive understanding of cancer.
  • This review provides a foundation for future investigations into TRP channel-targeted cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K